• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗寄生虫药物对线形盘尾丝虫第三期幼虫的体外活性研究。

Study on the activity of antiparasitic agents against Onchocerca lienalis third stage larvae in vitro.

作者信息

Court J P, Bianco A E, Townson S, Ham P J, Friedheim E

出版信息

Trop Med Parasitol. 1985 Jun;36(2):117-9.

PMID:4023552
Abstract

The in vitro drug response of third stage larvae of the cattle filarial worm Onchocerca lienalis has been studied. Larvae were maintained in Minimum Essential Eagles medium supplemented with 10% inactivated foetal calf serum and exposed to the following drugs: Mel W, caparsolate sodium, suramin, ivermectin, flubendazole, levamisole and amoscanate plus 3 novel melaminylthioarsenites. Antiparasitic activity of these compounds has been assessed on their killing effects and their ability to totally inhibit the moult from the third to the fourth stage. Unfortunately, moulting occurred at a low rate in the culture system used and was not suitable as a quantitative parameter for describing drug activity. However, the results indicated that if the rate of ecdysis could be increased by improving the culture conditions, moulting could be used in this manner since exsheathment has inhibited by certain compounds at concentrations where killing effects were less than 50%. Of the compounds evaluated ivermectin demonstrated good activity, totally preventing ecdysis at 0.001 microgram/ml. The drug assay system used in this study may offer a starting point for the eventual development of a meaningful and specific in vitro screen for new anti-Onchocerca agents.

摘要

对牛丝状线虫链尾盘尾丝虫第三期幼虫的体外药物反应进行了研究。幼虫饲养于添加10%灭活胎牛血清的最低必需 Eagle 培养基中,并暴露于以下药物:Mel W、卡巴胂钠、苏拉明、伊维菌素、氟苯达唑、左旋咪唑和氨硫脲,以及3种新型三聚氰胺基硫代亚砷酸盐。已根据这些化合物的杀伤效果及其完全抑制从第三期到第四期蜕皮的能力评估了它们的抗寄生虫活性。遗憾的是,在所使用的培养系统中蜕皮发生率较低,不适宜作为描述药物活性的定量参数。然而,结果表明,如果通过改善培养条件提高蜕皮率,蜕皮可用于此目的,因为在杀伤效果小于50%的浓度下,某些化合物可抑制脱鞘。在所评估的化合物中,伊维菌素表现出良好的活性,在0.001微克/毫升时完全阻止蜕皮。本研究中使用的药物检测系统可能为最终开发有意义且特异的新型抗盘尾丝虫药物体外筛选方法提供一个起点。

相似文献

1
Study on the activity of antiparasitic agents against Onchocerca lienalis third stage larvae in vitro.抗寄生虫药物对线形盘尾丝虫第三期幼虫的体外活性研究。
Trop Med Parasitol. 1985 Jun;36(2):117-9.
2
Drug activity against Onchocerca gutturosa males in vitro: a model for chemotherapeutic research on onchocerciasis.药物对牛盘尾丝虫雄虫的体外活性:盘尾丝虫病化疗研究的一个模型
J Helminthol. 1987 Dec;61(4):271-81. doi: 10.1017/s0022149x00010178.
3
Studies on the activity of the Ciba Geigy compounds CGP 6140, 20376, 20309 and 21833 against third and fourth stage larvae of Onchocerca volvulus.关于汽巴-嘉基化合物CGP 6140、20376、20309和21833抗盘尾丝虫第三期和第四期幼虫活性的研究。
Trop Med Parasitol. 1989 Mar;40(1):51-6.
4
Moulting and exsheathment of the infective larvae of Onchocerca lienalis (Filarioidea) in vitro.绵羊盘尾丝虫(丝虫总科)感染性幼虫在体外的蜕皮和脱鞘
Acta Trop. 1988 Mar;45(1):67-76.
5
In vitro drug screening in isolated male Onchocerca gibsoni using motility suppression.使用运动抑制法对分离出的雄性吉氏盘尾丝虫进行体外药物筛选。
Trop Med Parasitol. 1987 Jun;38(2):128-30.
6
[Use of surviving infectious larvae of Dipetalonema dessetae in study and research on filaricidal substances].[利用德氏双瓣线虫存活感染性幼虫进行杀丝虫物质的研究]
J Pharmacol. 1986 Jul-Sep;17(3):301-7.
7
An evaluation of implanted male Onchocerca gibsoni in mice as a screen for macrofilaricides against Onchocerca volvulus.对植入小鼠体内的雄性吉氏盘尾丝虫进行评估,作为抗盘尾丝虫病杀成虫剂的筛选方法。
Trop Med Parasitol. 1988 Dec;39 Suppl 4:472-4.
8
Morphological alterations of male Onchocerca volvulus after in vitro exposure to mel w and milbemycin a confirming the results of viability tests.体外暴露于米尔倍霉素w和米尔倍霉素a后,雄性盘尾丝虫的形态学改变证实了活力测试的结果。
Trop Med Parasitol. 1990 Dec;41(4):429-36.
9
The microfilaricidal activity of ivermectin in vitro and in vivo.伊维菌素在体外和体内的杀微丝蚴活性。
Tropenmed Parasitol. 1984 Mar;35(1):47-49.
10
In vitro assessment of the activity of anthelmintic compounds on adults of Onchocerca volvulus.抗蠕虫化合物对盘尾丝虫成虫活性的体外评估。
Acta Leiden. 1990;59(1-2):285-96.

引用本文的文献

1
Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.在盘尾丝虫病流行区生活并每三个月用伊维菌素治疗的个体比每年治疗的个体产生的新盘尾丝虫结节更少。
Parasit Vectors. 2020 May 15;13(1):258. doi: 10.1186/s13071-020-04126-x.